Linagliptin-associated bullous pemphigoid treated with rituximab

Dipeptidyl peptidase 4 (DPP-4) inhibitors are increasingly used these days in management of diabetes. There has been reported in a few case reports of increasing association between DPP-4 inhibitor use and bullous pemphigoid (BP). We report a case of association between linagliptin use and BP and su...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ Case Rep
Main Authors: Mani, Hariharasudan, Safo, Patrick, Onitilo, Adedayo A
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2019
Assuntos:
Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6768351/
https://ncbi.nlm.nih.gov/pubmed/31570343
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2019-229902
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados